Published September 19, 2023 | Version v1

CLINICAL AND PHARMACOLOGICAL AUDIT OF HEPATOPROTECTORS USED IN TREATMENT OF PATIENTS WITH CHRONIC LIVER DISEASES IN SOME HOSPITALS OF KHOREZM REGION - URGENCH BRANCH OF TASHKENT MEDICAL ACADEMY

  • 1. Professor, Department of Pharmacology and Clinical Pharmacology, Al-Khorazmiy St 28, Urgench City, Uzbekistan.
  • 2. Senior Lecturer, Ph. D, Department of Pharmacology and Clinical Pharmacology, Al-Khorazmiy St 28, Urgench City, Uzbekistan.
  • 3. Senior Lecturer, Department of Pharmacology and Clinical Pharmacology, Al-Khorazmiy St 28, Urgench City, Uzbekistan.
  • 4. Assistant, Department of Pharmacology and Clinical Pharmacology, Al-Khorazmiy St 28, Urgench City, Uzbekistan.

Description

Abstract

Retrospectively, pharmacoepidemiological methods were used to study 360 pieces of the history of diseases of patients with diseases of the hepatobiliary system, treated in the central polyclinic of the city of Urganch and the Khiva district medical association. For the study, the questionnaire included 35 names of hepatoprotectors used in practical medicine in Uzbekistan. It was revealed that pharmacotherapy of patients with hepatobiliary diseases in the central polyclinic of the city of Urganch and Khiva district medical association is adequate for the severity of the pathological process and corresponds to the recommendations recognized by the global community of gastroenterologists. In the treatment of patients with diseases of the hepatobiliary system, physicians used hepatoprotectors separately, as well as in a combined form.

Files

22CP23V20I9_8365676.pdf

Files (465.3 kB)

Name Size
md5:fddd0733b12447b85e4951407b66f3c5
465.3 kB Preview Download